Enzo Biochem (ENZ) Scheduled to Post Quarterly Earnings on Wednesday
Enzo Biochem (NYSE:ENZ) is scheduled to be releasing its earnings data on Wednesday, October 16th. Persons interested in registering for the company’s earnings conference call can do so using this link.
Enzo Biochem (NYSE:ENZ) opened at 2.46 on Tuesday. Enzo Biochem has a 1-year low of $1.72 and a 1-year high of $3.16. The stock has a 50-day moving average of $2.51 and a 200-day moving average of $2.30. The company’s market cap is $98.3 million.
Enzo Biochem, Inc (NYSE:ENZ) is an integrated life sciences and biotechnology company focused on harnessing biological processes to develop research tools, diagnostics and therapeutics and serves as a provider of test services, including esoteric tests, to the medical community.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.